EBI-话题@MedSci

#EBI#

97篇内容 | 2655人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1997121, encodeId=d8cf199e12193, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=Lancet：Inebilizumab可降低视神经脊髓炎谱系疾病 (NMOSD)发作风险, objectType=article, longId=179047, objectId=b78a1e90479f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b78a1e90479f, replyNumber=0, likeNumber=65, createdTime=2020-03-18, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b78a1e90479f, moduleTitle=Lancet：Inebilizumab可降低视神经脊髓炎谱系疾病 (NMOSD)发作风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b78a1e90479f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997109, encodeId=374c199e10958, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=欧洲CHMP推荐将Bluebird公司的基因疗法Zynteglo用于治疗输血依赖性β-地中海贫血, objectType=article, longId=163435, objectId=ce74163435a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce74163435a9, replyNumber=0, likeNumber=71, createdTime=2019-10-21, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce74163435a9, moduleTitle=欧洲CHMP推荐将Bluebird公司的基因疗法Zynteglo用于治疗输血依赖性β-地中海贫血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce74163435a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997110, encodeId=8bec199e11029, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：前列腺癌治疗药物新发现, objectType=article, longId=163701, objectId=ce94163e01ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce94163e01ab, replyNumber=0, likeNumber=71, createdTime=2019-06-05, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce94163e01ab, moduleTitle=EBioMedicine：前列腺癌治疗药物新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce94163e01ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997111, encodeId=8624199e111fc, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：细胞分裂周期蛋白20（CDC20）能够促使前列腺癌的恶化, objectType=article, longId=163949, objectId=320f16394970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=320f16394970, replyNumber=0, likeNumber=70, createdTime=2019-05-25, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=320f16394970, moduleTitle=EBioMedicine：细胞分裂周期蛋白20（CDC20）能够促使前列腺癌的恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=320f16394970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997113, encodeId=40a5199e1135f, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：胰腺癌检测研究新成果, objectType=article, longId=164711, objectId=e32a164e1102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e32a164e1102, replyNumber=0, likeNumber=124, createdTime=2020-02-13, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e32a164e1102, moduleTitle=EBioMedicine：胰腺癌检测研究新成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e32a164e1102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997117, encodeId=f808199e11733, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=Bluebirdβ-地中海贫血基因疗法Zynteglo，喜获欧盟有条件的上市许可, objectType=article, longId=167643, objectId=f63916e643e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f63916e643e2, replyNumber=0, likeNumber=61, createdTime=2019-11-16, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f63916e643e2, moduleTitle=Bluebirdβ-地中海贫血基因疗法Zynteglo，喜获欧盟有条件的上市许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f63916e643e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997107, encodeId=4498199e107cb, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=II期临床研究FUZE评估Debio 1347治疗晚期实体瘤的疗效, objectType=article, longId=160427, objectId=61c716042e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61c716042e5f, replyNumber=0, likeNumber=73, createdTime=2019-05-02, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61c716042e5f, moduleTitle=II期临床研究FUZE评估Debio 1347治疗晚期实体瘤的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61c716042e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997116, encodeId=e523199e11629, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=JCLA：基于Sebia琼脂糖凝胶检测系统的尿蛋白电泳显示lambda型FLC二聚体可能假迁移到“白蛋白”带位置, objectType=article, longId=167625, objectId=752016e62548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=752016e62548, replyNumber=0, likeNumber=77, createdTime=2020-02-29, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=752016e62548, moduleTitle=JCLA：基于Sebia琼脂糖凝胶检测系统的尿蛋白电泳显示lambda型FLC二聚体可能假迁移到“白蛋白”带位置, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=752016e62548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997114, encodeId=89eb199e11429, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=DDW 2019：Rebiotix将发布其基于微生物组修复研究治疗复发性梭状芽孢杆菌艰难梭菌的临床数据, objectType=article, longId=166311, objectId=73e416631194, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73e416631194, replyNumber=0, likeNumber=65, createdTime=2019-12-15, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73e416631194, moduleTitle=DDW 2019：Rebiotix将发布其基于微生物组修复研究治疗复发性梭状芽孢杆菌艰难梭菌的临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73e416631194)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997108, encodeId=5cbe199e10859, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：靶向内质网蛋白质氧化折叠通路治疗宫颈癌新策略, objectType=article, longId=162571, objectId=16c01625e110, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16c01625e110, replyNumber=0, likeNumber=66, createdTime=2020-01-16, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16c01625e110, moduleTitle=EBioMedicine：靶向内质网蛋白质氧化折叠通路治疗宫颈癌新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16c01625e110)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997115, encodeId=f004199e115cc, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：IL-2响应的减少与总lgE水平提高和过敏性鼻炎的加重相关, objectType=article, longId=166433, objectId=55eb166433ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55eb166433ae, replyNumber=0, likeNumber=70, createdTime=2020-02-25, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55eb166433ae, moduleTitle=EBioMedicine：IL-2响应的减少与总lgE水平提高和过敏性鼻炎的加重相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55eb166433ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997102, encodeId=9c4a199e10212, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：抗-丙二醛IgM抗体或可降低心脏病风险, objectType=article, longId=151127, objectId=f80215112ed8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f80215112ed8, replyNumber=0, likeNumber=58, createdTime=2018-10-30, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f80215112ed8, moduleTitle=EBioMedicine：抗-丙二醛IgM抗体或可降低心脏病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f80215112ed8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997105, encodeId=471f199e1058e, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：王宏林教授揭示乳香活性成分治疗银屑病新靶点和机制, objectType=article, longId=157548, objectId=528f15e548fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=528f15e548fa, replyNumber=0, likeNumber=80, createdTime=2019-10-17, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=528f15e548fa, moduleTitle=EBioMedicine：王宏林教授揭示乳香活性成分治疗银屑病新靶点和机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=528f15e548fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997100, encodeId=63d4199e10030, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：在过敏性鼻炎且伴随肥胖的患者中，瘦蛋白/骨桥蛋白能够调控2型辅助T细胞响应, objectType=article, longId=141538, objectId=29b914153846, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29b914153846, replyNumber=0, likeNumber=77, createdTime=2019-01-26, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29b914153846, moduleTitle=EBioMedicine：在过敏性鼻炎且伴随肥胖的患者中，瘦蛋白/骨桥蛋白能够调控2型辅助T细胞响应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29b914153846)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997112, encodeId=f32f199e11225, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：鉴别出开发新型癌症疗法的潜在靶点, objectType=article, longId=164180, objectId=246616418011, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=246616418011, replyNumber=0, likeNumber=97, createdTime=2020-03-11, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=246616418011, moduleTitle=EBioMedicine：鉴别出开发新型癌症疗法的潜在靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=246616418011)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997103, encodeId=694f199e10341, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=eBioMedicine：研究发现新的调控褐色脂肪组织活性的小分子药物, objectType=article, longId=151783, objectId=0f78151e83b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f78151e83b2, replyNumber=0, likeNumber=72, createdTime=2018-10-31, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f78151e83b2, moduleTitle=eBioMedicine：研究发现新的调控褐色脂肪组织活性的小分子药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f78151e83b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997097, encodeId=f40a199e09760, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EBioMedicine：对乙酰氨基酚是否会影响性激素并导致胎儿畸形, objectType=article, longId=130608, objectId=8cb9130608bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cb9130608bc, replyNumber=0, likeNumber=107, createdTime=2018-04-21, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cb9130608bc, moduleTitle=EBioMedicine：对乙酰氨基酚是否会影响性激素并导致胎儿畸形, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cb9130608bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997106, encodeId=9aab199e106b2, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=EbioMedicine：重大突破！明星“长寿药”终于用到人类身上了, objectType=article, longId=157936, objectId=a3cb15e93611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3cb15e93611, replyNumber=0, likeNumber=78, createdTime=2019-05-12, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3cb15e93611, moduleTitle=EbioMedicine：重大突破！明星“长寿药”终于用到人类身上了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3cb15e93611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997104, encodeId=07be199e104e1, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=PhaseBio宣布开展PB1046治疗肺动脉高压的IIb期临床试验, objectType=article, longId=154605, objectId=48e41546053a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48e41546053a, replyNumber=0, likeNumber=60, createdTime=2019-11-14, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48e41546053a, moduleTitle=PhaseBio宣布开展PB1046治疗肺动脉高压的IIb期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48e41546053a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997101, encodeId=d14b199e101a8, content=<a href='/topic/show?id=9221645e6f' target=_blank style='color:#2F92EE;'>#EBI#</a>, objectTitle=Regeneron和Bluebird Bio强强联手助力于T细胞疗法, objectType=article, longId=146074, objectId=f21e1460e46b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f21e1460e46b, replyNumber=0, likeNumber=62, createdTime=2018-09-05, rootId=0, userName=linagood, userId=1376173, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f21e1460e46b, moduleTitle=Regeneron和Bluebird Bio强强联手助力于T细胞疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f21e1460e46b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EBI

2020-05-29

linagood (审核中...)

前往app查看评论内容

#EBI#

Lancet：Inebilizumab可降低视神经脊髓炎谱系疾病 (NMOSD)发作风险

2020-03-18

linagood (审核中...)

前往app查看评论内容

#EBI#

欧洲CHMP推荐将Bluebird公司的基因疗法Zynteglo用于治疗输血依赖性β-地中海贫血

2019-10-21

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：前列腺癌治疗药物新发现

2019-06-05

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：细胞分裂周期蛋白20（CDC20）能够促使前列腺癌的恶化

2019-05-25

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：胰腺癌检测研究新成果

2020-02-13

linagood (审核中...)

前往app查看评论内容

#EBI#

Bluebirdβ-地中海贫血基因疗法Zynteglo，喜获欧盟有条件的上市许可

2019-11-16

linagood (审核中...)

前往app查看评论内容

#EBI#

II期临床研究FUZE评估Debio 1347治疗晚期实体瘤的疗效

2019-05-02

linagood (审核中...)

前往app查看评论内容

#EBI#

JCLA：基于Sebia琼脂糖凝胶检测系统的尿蛋白电泳显示lambda型FLC二聚体可能假迁移到“白蛋白”带位置

2020-02-29

linagood (审核中...)

前往app查看评论内容

#EBI#

DDW 2019：Rebiotix将发布其基于微生物组修复研究治疗复发性梭状芽孢杆菌艰难梭菌的临床数据

2019-12-15

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：靶向内质网蛋白质氧化折叠通路治疗宫颈癌新策略

2020-01-16

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：IL-2响应的减少与总lgE水平提高和过敏性鼻炎的加重相关

2020-02-25

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：抗-丙二醛IgM抗体或可降低心脏病风险

2018-10-30

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：王宏林教授揭示乳香活性成分治疗银屑病新靶点和机制

2019-10-17

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：在过敏性鼻炎且伴随肥胖的患者中，瘦蛋白/骨桥蛋白能够调控2型辅助T细胞响应

2019-01-26

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：鉴别出开发新型癌症疗法的潜在靶点

2020-03-11

linagood (审核中...)

前往app查看评论内容

#EBI#

eBioMedicine：研究发现新的调控褐色脂肪组织活性的小分子药物

2018-10-31

linagood (审核中...)

前往app查看评论内容

#EBI#

EBioMedicine：对乙酰氨基酚是否会影响性激素并导致胎儿畸形

2018-04-21

linagood (审核中...)

前往app查看评论内容

#EBI#

EbioMedicine：重大突破！明星“长寿药”终于用到人类身上了

2019-05-12

智慧医人 (审核中...)

前往app查看评论内容

#EBI#

PhaseBio宣布开展PB1046治疗肺动脉高压的IIb期临床试验

2019-11-14

linagood (审核中...)

前往app查看评论内容

#EBI#

Regeneron和Bluebird Bio强强联手助力于T细胞疗法

2018-09-05

科室
- - 订阅+
  - 更多科室
工具
服务